New Delhi, Nov. 18 -- Healthcare startup Qure.ai is betting on partnerships with central and state governments as it seeks to scale its artificial intelligence-led diagnostic tools, particularly for diseases like tuberculosis (TB). The focus on public sector contracts comes as AI uptake in India's private healthcare market remains slow.

The company, which offers AI tools for screening TB, lung cancer, and stroke, currently derives less than 5% of its overall revenue from India. However, CEO and founder Prashant Warier sees a "substantial opportunity" in tapping into the public health market, especially given the country's disproportionate burden of TB.

India accounted for 25% of the global TB cases in 2024, according to the WHO's Global...